Table 1. Demographics, vector exposure, clinical characteristics, and outcome of prospective cohort patients, by weekly evaluations.
Weekly Evaluations Only | Twice-Weekly Evaluations | P-Value | |
# (Column %) | # (Column %) | ||
Total N | 87 | 75 | – |
Female | 42 (48.8) | 47 (62.7) | 0.078 |
Average Age (Years) | 37.7 | 41.0 | 0.103 |
Age >35 Years Old | 47 (54.0) | 48 (64.0) | 0.229 |
Owns Phone | 71 (81.6) | 67 (89.3) | 0.168 |
Reported Frequent Alcohol Use | 58 (67.4) | 50 (66.7) | 0.917 |
Residence and Exposure to Principle Vector | |||
Residence Within City of Punata | 64 (73.6) | 59 (78.7) | 0.449 |
Average Years at Residence | 21.6 | 20.0 | 0.529 |
Home Previously Infested | 50 (58.1) | 52 (69.3) | 0.141 |
Average Years Since Infestation | 12.4 | 11.1 | 0.559 |
Pre-Treatment Clinical Characteristics | |||
Cardiac Symptoms | 16 (18.4) | 12 (16.0) | 0.688 |
NYHA Class>I | 19 (22.1) | 9 (12.0) | 0.092 |
GI Symptoms | 11 (12.6) | 8 (10.7) | 0.697 |
ECG Abnormalities | 32 (38.6) | 17 (23.9) | 0.052 |
Treatment Outcomes | |||
Completed Treatment | 76 (87.4) | 57 (76.0) | 0.039 |
Suspended Treatment | 6 (6.9) | 11 (14.7) | 0.108 |
Abandoned Treatment | 5 (5.7) | 7 (9.3) | 0.385 |